Physician
Owensboro Health Medical Group, INC
Owensboro Health Medical Group, INC was paid $10.59M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoOWENSBORO HEALTH MEDICAL GROUP, INC
OWENSBORO, KY 42301
OWENSBORO, KY 42301
33aNPI1376594242assigned 05/15/2006
33bProvider typeInternal Medicine Physician
28Total paid$10.59M
24GClaims325,091
24DCodes billed93
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Kentucky
Rank by total paid#2 of 231
Median peer was paid$77K
This provider vs. median138×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,563 | $956K | |
| 2019 | 31,471 | $879K | |
| 2020 | 27,400 | $864K | |
| 2021 | 46,206 | $1.57M | |
| 2022 | 67,841 | $2.09M | |
| 2023 | 67,648 | $2.41M | |
| 2024incomplete | 47,962 | $1.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 42,647 | 39,600 | $2.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 57,743 | 51,116 | $1.63M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 26,659 | 24,591 | $1.14M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 6.8% | 7,917 | 2,901 | $723K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.9% | 19,227 | 8,517 | $622K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.8% | 6,114 | 5,794 | $513K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.8% | 13,854 | 12,881 | $506K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.6% | 21,933 | 9,438 | $486K |
| 99223 | Prolong inpt eval add15 m | 3.6% | 5,440 | 5,076 | $386K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.8% | 11,909 | 11,633 | $295K |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.6% | 6,779 | 6,359 | $278K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.7% | 23,584 | 20,935 | $178K |
81 more codes
| 77063 | Screening digital breast tomosynthesis, bilateral | 1.2% | 6,939 | $132K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 16,585 | $119K |
| 99220 | 1.1% | 1,460 | $112K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.0% | 950 | $108K |
| 95806 | <1% | 1,060 | $106K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 5,646 | $100K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 859 | $75K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,381 | $58K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,300 | $39K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 530 | $34K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,172 | $34K |
| 95811 | <1% | 309 | $33K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,525 | $32K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,037 | $29K |
| 94060 | <1% | 1,602 | $28K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 526 | $28K |
| 74018 | <1% | 3,457 | $22K | |
| 73630 | <1% | 3,378 | $22K | |
| 77014 | <1% | 936 | $17K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 167 | $17K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,683 | $16K |
| 71271 | <1% | 478 | $16K | |
| 77427 | <1% | 179 | $15K | |
| 76642 | <1% | 635 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 852 | $13K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 575 | $13K |
| 94729 | <1% | 1,239 | $12K | |
| 73030 | <1% | 1,860 | $11K | |
| 94726 | <1% | 974 | $11K | |
| 99217 | <1% | 322 | $11K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 177 | $11K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 201 | $10K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 888 | $9K |
| 72110 | <1% | 834 | $9K | |
| 90686 | <1% | 642 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 113 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 357 | $8K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 52 | $8K |
| 99406 | <1% | 949 | $7K | |
| 73562 | <1% | 1,132 | $7K | |
| 73610 | <1% | 1,122 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 422 | $7K |
| 73130 | <1% | 986 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 176 | $6K |
| 73564 | <1% | 676 | $6K | |
| 99307 | <1% | 1,092 | $4K | |
| 72100 | <1% | 524 | $4K | |
| 99407 | <1% | 324 | $4K | |
| 73110 | <1% | 636 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 941 | $4K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 94 | $3K |
| 73502 | <1% | 446 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,161 | $3K |
| 90670 | <1% | 15 | $2K | |
| 99219 | <1% | 40 | $2K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 233 | $2K |
| 77065 | Tomosynthesis, mammo | <1% | 63 | $2K |
| 76536 | <1% | 64 | $1K | |
| 87634 | <1% | 29 | $1K | |
| 77263 | <1% | 12 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 62 | $965.42 |
| 77080 | <1% | 171 | $927.29 | |
| 99221 | <1% | 39 | $887.05 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 499 | $809.18 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $613.70 |
| 94618 | <1% | 26 | $612.21 | |
| 72050 | <1% | 51 | $598.54 | |
| 99442 | <1% | 79 | $543.90 | |
| 99225 | <1% | 19 | $542.04 | |
| 76770 | <1% | 25 | $533.10 | |
| 88738 | <1% | 110 | $479.87 | |
| Q3014 | Telehealth originating site facility fee | <1% | 68 | $467.83 |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 17 | $371.18 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 91 | $313.62 |
| 72040 | <1% | 29 | $253.20 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 345 | $198.17 |
| 81002 | <1% | 413 | $122.23 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $75.96 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | $14.42 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 124 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPENNINGTON, TERESA (CRED SPECIALIST)
Parent organizationOWENSBORO HEALTH INC
| Provider | Location | Paid |
|---|---|---|
| NP Geriatric Adult Care LLC | Cedar Bluff, VA | $141K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.